Monday 20th January 2014 |
Text too small? |
The number of houses sold in New Zealand fell in December from a year earlier, continuing a trend, though the national median sale price rose to a new record, according to Real Estate Institute figures.
The number of houses sold fell 1.1 percent to 5,688 in December from the same month a year earlier, and were down 18 percent from November, a bigger drop than the average decline, REINZ said in a statement. The fall in sales volumes was led by Manawatu/Wanganui, where turnover dropped 37 percent, followed by a 27 percent slide in Southland and a 24 percent decline in Wellington.
The median sale price rose 0.5 percent to $427,000 in December, and was up an annual 9.8 percent. Prices in Auckland, which have been driving growth over the past year, fell 3.2 percent to $620,000, and were up 12 percent on the year.
"The softer trend in sales noted in November 2013 continued into December," chief executive Helen O'Sullivan said. "Further data is needed over the next few months to determine if this is a new (price) trend, or a short-term effect caused by a change in the pace of sales at lower price points given the increased complexity some buyers in these price points now have to navigate."
In October, the Reserve Bank imposed restrictions on lending with small deposits as bubbling housing markets in Auckland and Christchurch, which typically account for half the nation's property turnover, raised fears about the nation's financial stability if there was a sharp correction.
The stratified housing index, which looks to smooth out peaks and troughs, fell 1 percent in December, and was up 9.2 percent in the year.
The average number of days to sell a property slowed to 32 days from 31 days in November, and was unchanged from a year earlier.
BusinessDesk.co.nz
No comments yet
December 27th Morning Report
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors